Targeted Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Targeted DNA Sequencing is the fastest growing segment, North America is the largest regional market

The Global Targeted Sequencing Market, valued at USD 3.90 Billion in 2024, is projected to experience a CAGR of 11.10% to reach USD 7.33 Billion by 2030. The Global Targeted Sequencing Market centers on a next-generation sequencing technique that precisely targets and analyzes specific genomic regions, such as particular genes or exons, rather than sequencing the entire genome. This focused approach provides high-depth coverage and accuracy for selected areas, enabling efficient and cost-effective identification of genetic variants critical for various applications.

Key Market Drivers

The increasing global burden of genetic disorders and cancer represents a primary driving force behind the expansion of the Global Targeted Sequencing Market. The critical need for precise diagnostic tools and methods for disease characterization fuels the demand for targeted sequencing, which offers highly accurate and in-depth analysis of specific genomic regions relevant to these conditions.

This technology enables earlier detection, guides personalized treatment strategies, and facilitates monitoring for recurrence or treatment response in oncology and rare disease settings. According to the World Health Organization, in February 2024, global cancer estimates for 2022 revealed approximately 20 million new cancer cases and 9.7 million deaths, highlighting the pervasive nature of this disease and the continuous requirement for advanced diagnostic solutions. Furthermore, targeted sequencing is instrumental in identifying the underlying genetic causes of rare diseases, which collectively affect millions worldwide.

Key Market Challenges

A significant challenge impeding the growth of the Global Targeted Sequencing Market is the absence of standardized guidelines and a unified consensus regarding the multitude of next-generation sequencing platforms and techniques. This fragmented landscape directly complicates widespread clinical adoption and the crucial processes of securing reimbursement for these advanced diagnostic tests. The lack of uniform standards creates ambiguity in test validation, interpretation, and reporting across different laboratories and healthcare providers.

This absence of standardization contributes to inconsistent payer policies, as each insurer may establish varying evidentiary requirements for assessing clinical utility, leading to unpredictable coverage and payment decisions. For instance, according to the College of American Pathologists, a 2.5% reduction in payment for pathology services, which includes molecular diagnostics, is anticipated starting January 2025, reflecting ongoing pressures on reimbursement and the complexities in valuing these intricate tests. Such financial uncertainty directly deters broader integration of targeted sequencing into routine clinical practice, limiting patient access to these critical diagnostic tools and consequently hindering overall market expansion.

Key Market Trends

Artificial intelligence and machine learning integration is profoundly transforming genomic data interpretation within targeted sequencing. These advanced computational methods are essential for efficiently analyzing the vast and complex datasets generated, enabling the rapid identification of subtle genetic variants and their clinical implications. This capability significantly enhances diagnostic precision and facilitates the development of personalized therapeutic approaches. Reflecting this growing importance, according to Roche, in April 2025, the company committed $50 billion over five years to its US pharmaceutical and diagnostics operations, including the establishment of a new research and development center focused on artificial intelligence research. This strategic investment highlights the industry’s reliance on AI to convert genomic information into actionable clinical intelligence.

Key Market Players Profiled:

MGI Tech Co., Ltd
GENEWIZ Inc
Agilent Technologies, Inc.
Daicel Arbor Biosciences
Danaher Corporation
Illumina, Inc.
LGC Biosearch Technologies
Pacific Biosciences of California Inc
CD Genomics
F. Hoffmann-La Roche Ltd

Report Scope:

In this report, the Global Targeted Sequencing Market has been segmented into the following categories:

By Product Type:

Kits/Panels and Assays
Instruments
Other

By Target Capture Type:

Targeted DNA Sequencing
Targeted RNA Sequencing
Others

By Target Enrichment Method:

Amplicon Sequencing
Hybridization Capture
Others

By End Users:

Academic and Research Institution
Pharmaceutical and Biotech Companies
Diagnostic & Clinical Laboratories
Other

By Application:

Oncology
Infectious Diseases
Cardiovascular Diseases
Reproductive Health
Rare Diseases
Neurological Disorders
Hereditary Diseases
Others

By Region:

North America
Europe
Asia-Pacific
South America
Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Targeted Sequencing Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Targeted Sequencing Market Outlook

5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Kits/Panels and Assays, Instruments, Other)
5.2.2. By Target Capture Type (Targeted DNA Sequencing, Targeted RNA Sequencing, Others)
5.2.3. By Target Enrichment Method (Amplicon Sequencing, Hybridization Capture, Others)
5.2.4. By End Users (Academic and Research Institution, Pharmaceutical and Biotech Companies, Diagnostic & Clinical Laboratories, Other)
5.2.5. By Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Reproductive Health, Rare Diseases, Neurological Disorders, Hereditary Diseases, Others)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map

6. North America Targeted Sequencing Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Target Capture Type
6.2.3. By Target Enrichment Method
6.2.4. By End Users
6.2.5. By Application
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Targeted Sequencing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Target Capture Type
6.3.1.2.3. By Target Enrichment Method
6.3.1.2.4. By End Users
6.3.1.2.5. By Application
6.3.2. Canada Targeted Sequencing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Target Capture Type
6.3.2.2.3. By Target Enrichment Method
6.3.2.2.4. By End Users
6.3.2.2.5. By Application
6.3.3. Mexico Targeted Sequencing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Target Capture Type
6.3.3.2.3. By Target Enrichment Method
6.3.3.2.4. By End Users
6.3.3.2.5. By Application

7. Europe Targeted Sequencing Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Target Capture Type
7.2.3. By Target Enrichment Method
7.2.4. By End Users
7.2.5. By Application
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Targeted Sequencing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Target Capture Type
7.3.1.2.3. By Target Enrichment Method
7.3.1.2.4. By End Users
7.3.1.2.5. By Application
7.3.2. France Targeted Sequencing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Target Capture Type
7.3.2.2.3. By Target Enrichment Method
7.3.2.2.4. By End Users
7.3.2.2.5. By Application
7.3.3. United Kingdom Targeted Sequencing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Target Capture Type
7.3.3.2.3. By Target Enrichment Method
7.3.3.2.4. By End Users
7.3.3.2.5. By Application
7.3.4. Italy Targeted Sequencing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Target Capture Type
7.3.4.2.3. By Target Enrichment Method
7.3.4.2.4. By End Users
7.3.4.2.5. By Application
7.3.5. Spain Targeted Sequencing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Target Capture Type
7.3.5.2.3. By Target Enrichment Method
7.3.5.2.4. By End Users
7.3.5.2.5. By Application

8. Asia-Pacific Targeted Sequencing Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Target Capture Type
8.2.3. By Target Enrichment Method
8.2.4. By End Users
8.2.5. By Application
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Targeted Sequencing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Target Capture Type
8.3.1.2.3. By Target Enrichment Method
8.3.1.2.4. By End Users
8.3.1.2.5. By Application
8.3.2. India Targeted Sequencing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Target Capture Type
8.3.2.2.3. By Target Enrichment Method
8.3.2.2.4. By End Users
8.3.2.2.5. By Application
8.3.3. Japan Targeted Sequencing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Target Capture Type
8.3.3.2.3. By Target Enrichment Method
8.3.3.2.4. By End Users
8.3.3.2.5. By Application
8.3.4. South Korea Targeted Sequencing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Target Capture Type
8.3.4.2.3. By Target Enrichment Method
8.3.4.2.4. By End Users
8.3.4.2.5. By Application
8.3.5. Australia Targeted Sequencing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Target Capture Type
8.3.5.2.3. By Target Enrichment Method
8.3.5.2.4. By End Users
8.3.5.2.5. By Application

9. Middle East & Africa Targeted Sequencing Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Target Capture Type
9.2.3. By Target Enrichment Method
9.2.4. By End Users
9.2.5. By Application
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Targeted Sequencing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Target Capture Type
9.3.1.2.3. By Target Enrichment Method
9.3.1.2.4. By End Users
9.3.1.2.5. By Application
9.3.2. UAE Targeted Sequencing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Target Capture Type
9.3.2.2.3. By Target Enrichment Method
9.3.2.2.4. By End Users
9.3.2.2.5. By Application
9.3.3. South Africa Targeted Sequencing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Target Capture Type
9.3.3.2.3. By Target Enrichment Method
9.3.3.2.4. By End Users
9.3.3.2.5. By Application

10. South America Targeted Sequencing Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Target Capture Type
10.2.3. By Target Enrichment Method
10.2.4. By End Users
10.2.5. By Application
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Targeted Sequencing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Target Capture Type
10.3.1.2.3. By Target Enrichment Method
10.3.1.2.4. By End Users
10.3.1.2.5. By Application
10.3.2. Colombia Targeted Sequencing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Target Capture Type
10.3.2.2.3. By Target Enrichment Method
10.3.2.2.4. By End Users
10.3.2.2.5. By Application
10.3.3. Argentina Targeted Sequencing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Target Capture Type
10.3.3.2.3. By Target Enrichment Method
10.3.3.2.4. By End Users
10.3.3.2.5. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Targeted Sequencing Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. MGI Tech Co., Ltd
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. GENEWIZ Inc
15.3. Agilent Technologies, Inc.
15.4. Daicel Arbor Biosciences
15.5. Danaher Corporation
15.6. Illumina, Inc.
15.7. LGC Biosearch Technologies
15.8. Pacific Biosciences of California Inc
15.9. CD Genomics
15.10. F. Hoffmann-La Roche Ltd

16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Targeted Sequencing market report include:

MGI Tech Co., Ltd
GENEWIZ Inc
Agilent Technologies, Inc.
Daicel Arbor Biosciences
Danaher Corporation
Illumina, Inc.
LGC Biosearch Technologies
Pacific Biosciences of California Inc
CD Genomics
F. Hoffmann-La Roche Ltd

Table Information

Report Attribute	Details
No. of Pages	185
Published	November 2025
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 3.9 Billion
Forecasted Market Value ( USD ) by 2030	$ 7.33 Billion
Compound Annual Growth Rate	11.1%
Regions Covered	Global
No. of Companies Mentioned	11

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3997EUR$4,500USD£3,492GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€4885EUR$5,500USD£4,268GBP

Key Market Drivers

Key Market Challenges

Key Market Trends

Key Market Players Profiled:

Report Scope:

By Product Type:

By Target Capture Type:

By Target Enrichment Method:

By End Users:

By Application:

By Region:

Competitive Landscape

Available Customizations:

Company Information

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Targeted Sequencing and Resequencing Market - Global Strategic Business Report

Targeted Sequencing Market - Global Forecast 2025-2032

Spatial Genomics and Transcriptomics Market - A Global and Regional Analysis: Focus on Product Type, Sample Type, Workflow, Application, End User, and Region - Analysis and Forecast, 2024-2034

Europe Targeted Sequencing Market: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture, End User, and Country - Analysis and Forecast, 2024-2033

Metagenomic Sequencing Market - Global Forecast 2025-2032